GNLX
GNLX
NASDAQ · Biotechnology

Genelux Corp

Penny Stocks Biotech Stocks Healthcare Stocks
$2.39
+0.04 (+1.70%)
As of Feb 8, 2:11 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +124.7% upside
Low Target $3.28
Average Target $5.37
High Target $6.50
Current Price $2.39
Current
$2.39
Target
$5.37
$3.28 $5.37 avg $6.50
Scenario Analysis
Bear Case
$3.28
37.2%
Low target
Base Case
$5.37
+124.7%
Avg target
Bull Case
$6.50
+172.0%
High target
Risk/Reward
4.6x
Highly favorable
Price in Context
52-Week High
$6.46
-63.0% from high
52-Week Low
$3.90
+-38.7% from low
Target vs 52W High
$5.37
-16.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
 Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
 Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
 Hold 42 48% $91.45 -54.5%